查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医疗外骨骼市场-2022-2029
市场调查报告书
商品编码
1140697

全球医疗外骨骼市场-2022-2029

Global Medical Exoskeleton Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期间（2022-2029 年），医疗外骨骼市场规模预计将以 48% 的复合年增长率增长。

外骨骼通过为肢体运动提供额外的力量来增加人类的体力。医用外骨骼有助于改善身体残疾者的生活质量，例如脊髓损伤、神经病、瘫痪和老年人。

市场动态

具有多自由度感官系统的低成本外骨骼机械手有望推动市场增长。

机器人技术和虚拟现实的快速发展需要更复杂的人机界面来实现高效的并行控制。外骨骼是一种可穿戴辅助技术，以高成本和大数据处理跟踪多维人体运动。或者，用于定制外骨骼的通用且具有成本效益的解决方案以最小的功耗监测人体上肢的所有可移动关节是摩擦电双向传感器。它用于识别相应的运动，例如二自由度（DOF）肩部旋转、手腕扭转和弯曲运动，并实时控制虚拟角色和机械臂。随后的运动分析从外骨骼和人体的结构完整性中提供了额外的物理参数，而无需引入其他传感器。这种外骨骼型传感系统作为一种低成本、高科技的人机界面具有很大的前景，用于在现实和虚拟世界中操纵物体，例如机器人自动化、医疗保健和培训。因此，从上述描述来看，预计它将成为预测期内的市场驱动力。

限制

外骨骼的有限功率范围、确保外骨骼获得批准用于医疗应用的监管挑战以及与医疗外骨骼相关的高成本预计将在预测期内阻碍市场。一些预期因素。例如，一个外骨骼的成本约为 45,000 美元，这是许多人买不起的。

行业分析

医疗外骨骼市场根据各种行业因素（包括未满足的需求、定价分析、供应链分析和监管分析）对市场进行深入分析。

COVID-19 影响分析

COVID-19 大流行对市场产生了积极影响。大流行给世界各地的医疗保健系统带来了前所未有的压力，包括护理的分配以及由于缺乏能力和资源，重症监护病房 (ICU) 无法安全地维持大量使用新兴机械通气的患者。严重影响临床管理。已经发现从仰卧位到俯卧位（正面）的姿势转换（PP）可以增强需要机械通气支持的急性呼吸窘迫综合征（ARDS）患者的氧合和通气动力学。因此，PP 在 COVID-19 大流行期间被广泛采用。例如，南希医院 ICU 在前 10 天进行了 116 次 PP 手术，这与他们通常一年内进行的手术数量相当。使用外骨骼帮助医护人员将机械通气的 COVID-19 患者置于俯卧位。让患者俯卧不是侵入性过程，但它是一项复杂的任务。

此外，人们越来越关注在工作场所人体工程学中使用外骨骼来减少体力工作量和患肌肉骨骼疾病的风险。外骨骼可以是主动的（电动的）或被动的，其中诸如弹簧之类的机械元件存储和回收能量，将负载从身体的一个部位转移到另一个部位。预计这将在预测期内提振医疗外骨骼市场。

细分分析

在医疗外骨骼市场中，预计被动外骨骼市场份额最大

2021 年，被动外骨骼市场份额最大。这部分受益，因为被动外骨骼通常比主动设备更便宜、更轻（例如，Collins 等人的脚踝外骨骼为 400 克，因此使其成为准被动（或半主动）设备）。结合动力和被动外骨骼特性在一个新的类别中可能会为外骨骼技术提供一个有前途的未来方向）。例如，EVO 是一种上半身提升外骨骼，旨在提高生产力和减少疲劳，并旨在消除颈部、肩部和背部的工作相关伤害。 EVO 基于业界首款工业背心 EksoVest，是世界上同类产品中最轻、最耐用、辅助性和自然顺从性的工业外骨骼。此外，无源设备最多只能提供可在运动之间切换的固定机械特性，例如在轨道上跑步或以恆定速度下坡。因此，从上述描述来看，这种市场细分预计将在预测期内占最大的市场份额。

区域分析

北美在全球医用外骨骼市场占有最大的市场份额

2021 年，北美市场份额最大。中风患病率上升、脊髓损伤 (SCI) 增加、老年人口增加、新产品发布和该地区主要市场参与者的批准是预计在预测期内推动市场发展的因素。任何运动都可能发生伤害，例如与其他运动员接触造成的创伤，或过度使用或误用身体部位。根据美国国家安全委员会 (NSC) 的数据，到 2020 年，骑自行车将造成近 426,000 人受伤，是所有体育和娱乐类别中最多的。有或没有设备，运动其次是大约 378,000 例，其次是使用全地形车、轻便摩托车和小型自行车，大约 230,000 例，使用滑板、踏板车和气垫板大约 218,000 例，我们排名第四。

此外，与游泳等非接触性运动相比，人们越来越担心足球等运动中的脑震盪风险。此外，美国食品药品监督管理局（Food and Drug Administration）（ FDA ）于 2020 年批准了 501（k）许可，将 Ekso Bionics 的机器人外骨骼 EksoNR 商业化，用于获得性脑损伤（ ABI ）患者。 EksoNR 是 FDA 批准的第一个用于 ABI 康復的外骨骼设备，将设备的范围扩展到更广泛的患者。因此，从上述陈述来看，预计北美地区将在预测期内占据最大的市场份额。

竞争格局

医疗外骨骼市场的主要参与者是 Ekso Bionics Holdings, Inc.、ReWalk Robotics Ltd.、Exoskeleton Report LLC、Parker Hannifin Corp、CYBERDYNE Inc、Bionik Laboratories Corp、Gogoa Mobility Robots、Hocoma AG、Wearable Robotics SR、B -TEMIA Inc.等。这些公司在医疗外骨骼市场占有很大份额。

这里是 Hocoma AG。

概述

Hocoma 是开发、生产和营销用于功能性运动治疗的机器人和基于传感器的设备的全球领导者。电气和生物医学工程师 Gery Colombo 和 Matthias Jorg 以及经济学家 Peter Hostettler 于 1996 年作为有限责任公司创立了这家瑞士医疗技术公司。 Hocoma 与领先的诊所和研究机构合作，创造尖端的治疗解决方案。大约 160 名员工在苏黎世附近的总部和美国、新加坡和斯洛文尼亚的子公司工作。我们拥有来自 25 个国家/地区的员工，是一家真正的全球化公司。瑞士 Hokoma 总部 35% 的员工是外国人，这增加了公司的多样性。

产品组合

ArmeoPower：ArmeoPower 专为康復早期阶段的手臂和手部治疗而设计。该设备允许患有严重运动障碍的患者进行高度重复（高强度）的运动，这对于运动再学习最重要。

本报告提供 45 多个市场数据表、40 多个图表和 180 页有关全球医疗外骨骼市场的信息。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 第 3 章：按组件划分的市场细分
  • 按类型划分的市场细分
  • 按产品划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 配备多自由度感官系统的低成本外骨骼机械手有望推动市场增长。
    • 限制
      • 预计医疗外骨骼的高成本将阻碍市场增长。
    • 市场机会
    • 影响分析

第5章行业分析

  • 供应链分析
  • 定价分析
  • 法律法规分析
  • 未满足的需求

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按组件

  • 硬件
    • 传感器
    • 执行器
    • 控制系统
    • 电源
    • 其他
  • 软件

第 8 章按类型

  • 动力外骨骼
  • 被动外骨骼

第 9 章按部分

  • 下半身外骨骼
  • 上身外骨骼

第 10 章按应用程序

  • 脊髓损伤
  • 创伤
  • 中风
  • 脑瘫
  • 其他

第 11 章，最终用户

  • 康復中心
  • 物理治疗设施
  • 其他

第 12 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 13 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 14 章公司简介

  • Ekso Bionics Holdings, Inc.
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • ReWalk Robotics Ltd.
  • Exoskeleton Report LLC
  • Parker Hannifin Corp
  • CYBERDYNE Inc.
  • Bionik Laboratories Corp
  • Gogoa Mobility Robots
  • Hocoma AG
  • Wearable Robotics SRL
  • B-TEMIA Inc（LIST NOT EXHAUSTIVE）

第15章 DataM

简介目录
Product Code: DMMD4650

Market Overview

Medical Exoskeleton Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 48% during the forecast period (2022-2029).

Exoskeletons are used to enhance a human's physical strength by offering additional strength to limb movements. Medical exoskeletons help physically challenged persons, such as spinal cord injuries, neurological disorders, paralysis, or aged persons to enhance their quality of life.

Market Dynamics

A low-cost exoskeleton manipulator with enhanced multiple degrees of freedom sensory system is expected to drive market growth.

Rapid advancements in robotics and virtual reality necessitate more complex human-machine interfaces to achieve efficient parallel control. The exoskeleton is a wearable assistive technology that tracks multi-dimensional human motions at a high cost and extensive data processing. Alternatively, a universal and cost-effective solution to a customized exoskeleton for monitoring all of the movable joints of the human upper limbs with minimal power consumption is a triboelectric bi-directional sensor. The corresponding movements, which include two degrees of freedom (DOF) shoulder rotations, wrist-twisting, and bending motions, are identified and used to control the virtual character and robotic arm in real-time. The subsequent kinetic analysis delivers additional physical parameters without introducing other sensors due to the structural consistency between the exoskeleton and the human body. This exoskeleton sensory system has a lot of promise as a low-cost, high-tech human-machine interface for manipulating objects in the real and virtual worlds, such as robotic automation, healthcare, and training. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Limited Power Range of exoskeleton, regulatory challenges for securing approvals for exoskeletons' medical applications, and the high cost associated with Medical Exoskeleton are some of the factors that the market is expected to get hampered in the forecast period. For instance, many people cannot afford an exoskeleton since they cost roughly $45,000.

Industry Analysis

The medical exoskeleton market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic had a positive impact on the market. The pandemic has put a strain on healthcare systems around the world like never before, with severe implications for clinical management, including rationing of care and the inability of Intensive Care Units (ICUs) to safely maintain a high number of patients on mechanical ventilation during the surge due to a lack of capacity and resources. Prone positioning (PP), or repositioning a patient from a supine to a prone position (i.e., on their front side), has been shown to enhance oxygenation and ventilatory mechanics in Acute Respiratory Distress Syndrome (ARDS) patients who require mechanical ventilatory assistance. As a result, during the COVID-19 pandemic, PP was widely employed. For instance, in the first ten days of the outbreak, the ICU at Nancy Hospital did 116 PP maneuvers, similar to the number of maneuvers they regularly perform in a year. Using exoskeletons to aid medical professionals during prone positioning of mechanically ventilated COVID-19 patients. Although putting a patient into the prone position is not an invasive process, it is complicated.

Moreover, there has been increasing interest in employing exoskeletons for workplace ergonomics to reduce physical workload and the risks of developing musculoskeletal disorders. Exoskeletons can be active (motorized) or passive, in which case mechanical elements such as springs store and restore energy, transferring the load from one body part to another. Thus, this is owing to boost the medical exoskeleton market in the forecast period.

Segment Analysis

Passive Exoskeleton segment is expected to hold the largest market share in medical exoskeleton market

The passive exoskeleton segment accounted for the largest market share in 2021. The segment is benefited because Passive exoskeletons are typically cheaper and lighter than active devices (e.g., Collins et al.'s ankle exoskeleton is 400 g, thereby, the combination of powered and passive exoskeleton characteristics in a new class of pseudo-passive (or semi-active) devices may provide a promising future direction for exoskeleton technology. For instance, EVO is an upper-body lifting exoskeleton designed to increase productivity and reduce fatigue, intending to eliminate work-related injuries to the neck, shoulder, and back. Building upon the industry's first industrial vest, EksoVest, EVO is the world's most lightweight, durable, assistive, and naturally-tracking industrial exoskeleton of its kind. Moreover, Passive devices can only offer fixed mechanical properties that are at best only switchable between locomotion bouts such as running on a track or hiking downhill at a fixed speed. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global medical exoskeleton market

North America accounted for the largest market share in 2021. The increasing prevalence of stroke, a growing number of spinal cord injuries (SCI), rising geriatric population, launches of new products, and approvals by leading market players in the region are some factors that the market is expected to boost the forecast period. For instance, injuries can occur in any sport, whether from the trauma of contact with other players or from overuse or misuse of a body part. According to the National Safety Council (NSC), in 2020, bicycling accounted for about 426,000 injuries, most of any sports and recreation category. With or without equipment, exercise followed with about 378,000 injuries, while ATV, moped and minibike use with 230,000 injuries, and skateboard, scooter and hoverboard use, with 218, 00 injuries, ranked third and fourth.

Moreover, the concern is growing about the risks of sports-related concussions such as football can be expected to result in a higher number of injuries than a noncontact sport such as swimming. Additionally, The US Food and Drug Administration (FDA) granted Ekso Bionics 501(k) permission in 2020 to commercialize their EksoNR robotic exoskeleton for patients with acquired brain damage (ABI). EksoNR is the first exoskeleton device to be cleared by the FDA for rehabilitation use with ABI, broadening the device's use to a far larger range of patients. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the medical exoskeleton market are Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Exoskeleton Report LLC, Parker Hannifin Corp, CYBERDYNE Inc., Bionik Laboratories Corp, Gogoa Mobility Robots, Hocoma AG, Wearable Robotics SR and B-TEMIA Inc.

Hocoma AG:

Overview:

Hocoma is the global industry leader in robotic and sensor-based devices for development, production, and marketing functional movement therapy. The electrical and biomedical engineers Gery Colombo and Matthias Jorg, as well as the economist Peter Hostettler, formed the Swiss medical technology firm in 1996 as a limited liability corporation. Hocoma creates cutting-edge therapy solutions in collaboration with top clinics and research institutions. Hocoma employs about 160 people at its headquarters near Zurich and its subsidiaries in the United States, Singapore, and Slovenia. They are a genuinely global organization, with employees from 25 different nations. 35 percent of the personnel at Hocoma's headquarters in Switzerland are international citizens, which adds to the company's diversity.

Product Portfolio:

ArmeoPower: The ArmeoPower has been specifically designed for arm and hand therapy in an early rehabilitation stage. The device enables even patients with severe movement impairments to perform exercises with high repetitions (high intensity), which is paramount for relearning motor function.

The global medical exoskeleton market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Component
  • 3.2. Market Snippet by Type
  • 3.3. Market Snippet by Extremity
  • 3.4. Market Snippet by Application
  • 3.5. Market Snippet by End User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. A low-cost exoskeleton manipulator with enhanced multiple degrees of freedom sensory system is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of medical exoskeleton are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component Segment
  • 7.2. Hardware*
    • 7.2.1. Sensor
    • 7.2.2. Actuator
    • 7.2.3. Control System
    • 7.2.4. Power Source
    • 7.2.5. Others
    • 7.2.6. Introduction
    • 7.2.7. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Software

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type Segment
  • 8.2. Powered Exoskeleton*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Passive Exoskeleton

9. By Extremity

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 9.1.2. Market Attractiveness Index, By Extremity Segment
  • 9.2. Lower Body Exoskeleton*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Upper Body Exoskeleton

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application Segment
  • 10.2. Spinal Cord Injury*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Trauma
  • 10.4. Stroke
  • 10.5. Cerebral Palsy
  • 10.6. Others

11. By End-user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Rehabilitation Centers*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 11.3. Physiotherapy Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Extremity
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Ekso Bionics Holdings, Inc.*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. ReWalk Robotics Ltd.
  • 14.3. Exoskeleton Report LLC
  • 14.4. Parker Hannifin Corp
  • 14.5. CYBERDYNE Inc.
  • 14.6. Bionik Laboratories Corp
  • 14.7. Gogoa Mobility Robots
  • 14.8. Hocoma AG
  • 14.9. Wearable Robotics SRL
  • 14.10. B-TEMIA Inc (*LIST NOT EXHAUSTIVE)

15. DataM Intelligence

  • 15.1. Appendix
  • 15.2. About Us and Applications
  • 15.3. Contact Us